Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | OxyContin 5mg modified-release tablets (Napp Pharmaceuticals Ltd) |
| BNF code | 0407020ADBCAEAK |
| Virtual Medicinal Product | Oxycodone 5mg modified-release tablets |
| Name | OxyContin 5mg modified-release tablets |
| Date of name applicability | 15 Apr 2009 |
| Previous name | OxyContin 5mg tablets |
| Supplier | Napp Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| OxyContin 5mg modified-release tablets (Napp Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.